These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28870764)

  • 1. Supersaturating drug delivery systems: The potential of co-amorphous drug formulations.
    Laitinen R; Löbmann K; Grohganz H; Priemel P; Strachan CJ; Rades T
    Int J Pharm; 2017 Oct; 532(1):1-12. PubMed ID: 28870764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Felodipine-indomethacin" co-amorphous supersaturating drug delivery systems: "Spring-parachute" process, stability, in vivo bioavailability, and underlying molecular mechanisms.
    Li YW; Zhang HM; Cui BJ; Hao CY; Zhu HY; Guan J; Wang D; Jin Y; Feng B; Cai JH; Qi XR; Shi NQ
    Eur J Pharm Biopharm; 2021 Sep; 166():111-125. PubMed ID: 34119671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM; Lee PI
    Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
    Alhalaweh A; Bergström CAS; Taylor LS
    J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in co-amorphous drug formulations.
    Dengale SJ; Grohganz H; Rades T; Löbmann K
    Adv Drug Deliv Rev; 2016 May; 100():116-25. PubMed ID: 26805787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review.
    Yu DG; Li JJ; Williams GR; Zhao M
    J Control Release; 2018 Dec; 292():91-110. PubMed ID: 30118788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
    Sarode AL; Wang P; Obara S; Worthen DR
    Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in Supersaturation and Phase Behavior of Ezetimibe Amorphous Solid Dispersions upon Dissolution in Different Biorelevant Media.
    Elkhabaz A; Sarkar S; Dinh JK; Simpson GJ; Taylor LS
    Mol Pharm; 2018 Jan; 15(1):193-206. PubMed ID: 29161509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.
    Ruponen M; Visti M; Ojarinta R; Laitinen R
    Eur J Pharm Biopharm; 2018 Aug; 129():247-256. PubMed ID: 29894814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining in vitro dissolution/permeation with microdialysis sampling: Capabilities and limitations for biopharmaceutical assessments of supersaturating drug formulations.
    Holzem FL; Jensen IH; Petrig Schaffland J; Stillhart C; Brandl M; Bauer-Brandl A
    Eur J Pharm Sci; 2023 Sep; 188():106533. PubMed ID: 37480963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release amorphous solid dispersions.
    Maincent J; Williams RO
    Drug Deliv Transl Res; 2018 Dec; 8(6):1714-1725. PubMed ID: 29498004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ternary Solid Dispersions: A Review of the Preparation, Characterization, Mechanism of Drug Release, and Physical Stability.
    Budiman A; Lailasari E; Nurani NV; Yunita EN; Anastasya G; Aulia RN; Lestari IN; Subra L; Aulifa DL
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions.
    Ashwathy P; Anto AT; Sudheesh MS
    Drug Dev Ind Pharm; 2021 Jan; 47(1):1-11. PubMed ID: 33494623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
    Han YR; Lee PI
    Mol Pharm; 2017 Jan; 14(1):206-220. PubMed ID: 28043130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.
    Arca HÇ; Mosquera-Giraldo LI; Dahal D; Taylor LS; Edgar KJ
    Mol Pharm; 2017 Nov; 14(11):3617-3627. PubMed ID: 28872867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.
    Trasi NS; Taylor LS
    J Pharm Sci; 2015 Aug; 104(8):2583-93. PubMed ID: 26059413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supersaturating drug delivery systems containing fixed-dose combination of two antihypertensive drugs: Formulation, in vitro evaluation and molecular metadynamics simulations.
    Pinto JMO; Leão AF; Bazzo GC; Mendes C; Madureira LMP; Caramori GF; Parreira RLT; Stulzer HK
    Eur J Pharm Sci; 2021 Aug; 163():105860. PubMed ID: 33901683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.
    Shi Q; Li F; Yeh S; Moinuddin SM; Xin J; Xu J; Chen H; Ling B
    AAPS PharmSciTech; 2021 Dec; 23(1):16. PubMed ID: 34893936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.